Medtronic 'smart' brain implant ramps up for human epilepsy trials; Device interoperability standards on their way

 @FierceMedDev: Coming soon: we'll find out if Intuitive Surgical's earnings slowed in Q3 as predicted. Let the speculation begin. More | Follow @FierceMedDev

 @MarkHFierce: Medtech industry's efficiency reaches new level, PWC report concludes. Article | Follow @MarkHFierce

 @DamianFierce: A federal court has tossed Fresenius' $83M Medicare fraud judgement. More  | Follow @DamianFierce

> Medtronic ($MDT) plans next year to begin patient testing of a new "smart" brain implant designed to manage epilepsy. Story

>  In other Medtronic news, the company has obtained a U.S. patent for a technology that would power implanted medical devices from an outside source such as a chair, blanket or clothing. Story

> Plans are underway to develop standards on medical device interoperability, an initiative fostered by the Association for the Advancement of Medical Instrumentation and Underwriters Laboratories. Release

> Medizinisch Diagnostiche Institute, Germany's largest clinical laboratory, plans to make a sizeable investment to develop its diagnostics and pathological lab presence in India. Story

> Stryker ($STK) is rolling out a new computer-assisted surgery system designed to help treat hip fractures. Release

> The University of Rochester in New York is enhancing its entrepreneurial focus on device development in the context of an academic degree. Its new Center for Medical Technology Innovation will combine talent from its engineering and medical schools with its Center for Entrepreneurship in a master's degree program. Item

Biotech News

 @FierceBiotech: Alzheimer's drug builds new brain cell connections in rats. Story | Follow @FierceBiotech

 @JohnCFierce: New FDA lung cancer OK for Celgene's Abraxane should boost sales. More | Follow @JohnCFierce

 @RyanMFierce: Biotech regulars should appreciate this. Actress Jennifer Aniston investing in a Bob Langer company. More | Follow @RyanMFierce

> Intercept Pharma, Kythera Bio jump out of the IPO gate. Story

> NPS Pharma shares jump on upbeat FDA review of Gattex. News

> Vertex's new data on CF drug cocktail doesn't disappoint. Report

Pharma News

@FiercePharma: How is the U.K.'s fund for NICE-nixed cancer drugs faring? Total spent since 10/2010: £180.9M on 18K+ patients. Report | Follow @FiercePharma

> Novartis, Sanofi unveil data backing their rival MS pills. Story

> New FDA lung cancer OK for Celgene's Abraxane should boost sales. Article

> Pfizer aims to keep CEO off the stand in Chantix trial. News